Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ED-Initiated School-based Asthma Medication Supervision
NCT03952286Phase 4Completed
- Sponsor
- University of Arizona
- Start
- Aug 2019
- Primary completion
- Dec 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in asthma (2 arms), sponsored by University of Arizona. Primary endpoint: 90-day Emergency Department (ED) Recidivism. Started Aug 2019; status: completed.
02
Conditions
asthma
Beyond the preview
Go deeper on NCT03952286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03952286.